Sionna Therapeutics Inc. (SION)
NASDAQ: SION
· Real-Time Price · USD
31.93
-0.79 (-2.41%)
At close: Oct 17, 2025, 3:59 PM
31.93
0.00%
After-hours: Oct 17, 2025, 04:32 PM EDT
Sionna Therapeutics Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
Revenue | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a |
Operating Income | -70.56M | -50.33M | -41.37M |
Interest Income | 8.17M | 2.77M | 1.13M |
Pretax Income | -61.69M | -47.26M | -40.24M |
Net Income | -61.69M | -47.26M | -40.24M |
Selling & General & Admin | 12.6M | 9.71M | 6.77M |
Research & Development | 57.29M | 40.63M | 34.6M |
Other Expenses | n/a | n/a | n/a |
Operating Expenses | 70.56M | 50.33M | 41.37M |
Interest Expense | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a |
Cost & Expenses | 70.56M | 50.33M | 41.37M |
Income Tax Expense | n/a | n/a | n/a |
Shares Outstanding (Basic) | 42.44M | 27.8M | 17.33M |
Shares Outstanding (Diluted) | 42.44M | 27.8M | 17.33M |
EPS (Basic) | -1.45 | -1.7 | -2.32 |
EPS (Diluted) | -15.99 | -1.7 | -2.32 |
EBITDA | -69.89M | -49.75M | -41.25M |
EBIT | -70.56M | -50.33M | -41.37M |
Depreciation & Amortization | 668K | 583K | 122K |
Source: Financial Modeling Prep. Financial Sources.